The FDA has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

Caused by the bacterium Chlamydia trachomatis, chlamydia is a common bacterial infection of the reproductive tract that can lead to infertility and pregnancy complications. The vaccine candidate ...

Sanofi’s vaccine is designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis, which is responsible for the most common sexually ...

The bacteria behind chlamydia can colonize the gut, and from that hiding place, they may act as a source of repeated ...

It is different from Chlamydia trachomatis, which is the strain associated with sexually transmitted infections. Researchers said the DNA of the bacteria found in the patient showed that it was an ...

Trachoma, once affecting 90% of Vietnamese people, has officially been declared eliminated after seven decades of national effort.

Sanofi’s chlamydia vaccine candidate was designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. The Food and Drug Administration (FDA ...